It is possible that due to elevated glucose levels, as frequently observed in obesity and MetS, the glycolysis‐mediated ACE2 upregulation in the lung macrophages of these patients subsequently increases SARS‐CoV‐2 cell invasion, contributing to an increased risk to get infected with SARS‐CoV‐2 (Figure 1). This evidence concerns the gene ACE2 and metabolic syndrome.